Providing further support for this, we found that administering recombinant IL-18BP to CarinhKO mice reversed the severe colitis phenotype of CarinhKO mice, as evidenced by our histological observations and the ultimate restoration of body weight and colon length (Fig. 3r–t). This evidence concerns the gene IL18BP and colitis.